Drugs of the Future
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
Indexed in the following public directories
Scopus 
SJR
- PublisherPROUS SCIENCE, SAU-THOMSON REUTERS
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1976
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Drugs of the Future been publishing? 
The Drugs of the Future has been publishing since 1976 till date.
How frequently is the Drugs of the Future published?
Drugs of the Future is published Monthly.
Who is the publisher of Drugs of the Future?
The publisher of Drugs of the Future is PROUS SCIENCE, SAU-THOMSON REUTERS.
How can I view the journal metrics of Drugs of the Future on editage?
For the Drugs of the Future metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Drugs of the Future?
The eISSN number is 2013-0368 and pISSN number is 0377-8282 for Drugs of the Future.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Medical genetics, Receptor antagonist, Molecular targets, Monoclonal antibody, Topoisomerase, Cancer immunotherapy, DNA Gyrase Inhibitors, Calcitonin gene-related peptide, RNA polymerase, Anaphylatoxin C5a, Resistant hypertension, Margetuximab, Autism spectrum disorder, Cancer research, Cytochrome b, Calcitonin gene-related peptide receptor antagonist, Drug discovery, Cancer therapy, Antibody-drug conjugate, Dipeptidyl peptidase.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.